Agreement of peripapillary vessel density among three optical coherence tomography angiography devices

Completed

• Conditions: Healthy volunteersGlaucomaOptic neuropathy; Optical Coherence Tomography Angiography; Glaucoma; Optic neuropathy; Agreement

• Registration Number: TCTR20210323007
• Lead Sponsor: Faculty of Medicine Chulalongkorn University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-10-31
• Study Start: 2021-03-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

Age above 17 years old
Normal population
BCVA 20/40 or better
Normal anterior segment and dilated fundus examination
Normal OCT disc, disc photography, VF
No family history of glaucoma or optic neuropathy
Glaucoma
Glaucomatous ONH
Optic neuropathy without edematous ONH

Exclusion Criteria

Poor fixation leading to motion or doubling artifacts
Presence of media opacification that obscure retinal vasculature
Presence of retinal pathology
Presence of refractive error greater than -6.00 to +6.00 D

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Agreement of OCTA devices including RTVue XR Avanti, PLEX Elite 9000, DRI-OCT Triton 2 years Peripapillary vessel density

Secondary Outcome Measures

Name	Time	Method
Agreement of OCTA devices, including RTVue XR Avanti, PLEX Elite 9000, DRI-OCT Triton in healthy eyes, glaucomatous eyes, optic neuropathy eyes. 2 years Peripapillary vessel density